Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00714_DB01623_nanopub.RAKASdSKL0ovCZ4nPE10aPOX8xAbHiNMkW_RuQrrNK9e0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00714_DB01623 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00714_DB01623 label "DDI between Apomorphine and Thiothixene - May cause additive QTc-prolonging effects. Increased risk of ventricular arrhythmias. Thiothixene may also antagonize the effects of the anti-Parkinsonian agent, Apomorphine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or doses changed. [drugbank_resource:DB00714_DB01623]" assertion.
- drugbank_resource:DB00714_DB01623 identifier "drugbank_resource:DB00714_DB01623" assertion.
- drugbank_resource:DB00714_DB01623 title "DDI between Apomorphine and Thiothixene - May cause additive QTc-prolonging effects. Increased risk of ventricular arrhythmias. Thiothixene may also antagonize the effects of the anti-Parkinsonian agent, Apomorphine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or doses changed." assertion.
- drugbank:DB01623 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00714_DB01623 assertion.
- drugbank:DB00714 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00714_DB01623 assertion.